IRWD FY 2025 Earnings — Ironwood Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

IRWDIronwood Pharmaceuticals, Inc.

$629M

FY 2025 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$296M-15.7% YoY

Gross Profit

$294M99.4% margin

Operating Income

$119M40.1% margin

Net Income

$24M8.1% margin

EPS (Diluted)

$0.15

Cash Flow

Operating Cash Flow

$127M

Free Cash Flow

$127M

Stock-Based Comp.

$17M

Balance Sheet

Total Assets

$397M

Total Liabilities

$659M

Stockholders' Equity

-$262M

Cash & Equivalents

$215M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$296M	$351M	-15.7%
Gross Profit	$294M	$344M	-14.4%
Operating Income	$119M	$93M	+27.5%
Net Income	$24M	$880,000	+2629.2%